AD/PD™ 2023: Striving for a better future for all those affected by neurodegenerative diseases.
AD/PD™ focuses on basic science and translational and clinical research to bring you:
- New insights on disease mechanisms and etiologies.
- The latest findings from clinical trials.
- Innovative outlooks on therapy and prevention.
- Advances in diagnostic markers.
- Successful strategies to enhance collaboration between academia and industry.
- A great opportunity to interact with peers and experts in neurodegenerative diseases.